Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia

Association of Neutrophil- Lymphocyte Count Ratio and Microbial Infection in Hospitalized Patients

NCT06759662 ·Status: NOT_YET_RECRUITING

Drug Resistance Factors In Healthcare-associated Pneumonia

NCT02736097 ·Status: COMPLETED

Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression

NCT05688774 ·Status: RECRUITING

Clinical Characteristics and Microbiology of Community-Acquired Pneumonia

NCT03098914 ·Status: UNKNOWN

Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.

NCT06259110 ·Status: NOT_YET_RECRUITING

Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia

NCT04332913 ·Status: UNKNOWN

Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital

NCT04481360 ·Status: UNKNOWN

Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19

NCT04359706 ·Status: COMPLETED

Co-infection Management in COVID-19 Critically Ill

NCT04382092 ·Status: COMPLETED ·Phase: NA

Immune Changes in Severe COVID-19 Pulmonary Infections

NCT04386395 ·Status: COMPLETED

Lung Bacteriobiota and Influenza Mortality

NCT04131296 ·Status: UNKNOWN

Pattern and Outcomes of Chest Diseases

NCT06053528 ·Status: UNKNOWN

Invasive Pulmonary Aspergillosis Complicating Influenza Infection

NCT03391492 ·Status: COMPLETED

Model to Predict Coinfection in Elderly Patients With COVID-19

NCT06321367 ·Status: COMPLETED

Improving Antibiotic Use in Acute Care Treatment

NCT00144040 ·Status: COMPLETED ·Phase: NA

Predictors of Improvement and Deterioration of Community Acquired Pneumonia in Children

NCT06720441 ·Status: NOT_YET_RECRUITING

Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia

NCT04334850 ·Status: COMPLETED ·Phase: NA

The Association Mechanism Between the Microbiome and the Development of Community Pneumonia Was Studied Based on the Analysis of Pulmonary Microbiota - Host Interaction Network

NCT06896019 ·Status: ACTIVE_NOT_RECRUITING

Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia

NCT03452826 ·Status: COMPLETED ·Phase: NA

Pharmacokinetics of Levofloxacin in Intensive Care Unit

NCT02018081 ·Status: COMPLETED ·Phase: PHASE4

Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia

NCT05903352 ·Status: RECRUITING ·Phase: PHASE3

Assessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity Score

NCT04135183 ·Status: UNKNOWN ·Phase: NA

Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients

NCT06566898 ·Status: RECRUITING

Microecology and Host Immunity in Patients With Severe COVID-19 Infection

NCT05670275 ·Status: UNKNOWN

Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients

NCT04674410 ·Status: WITHDRAWN